General Health

A significant number of Parkinson’s disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions. In a new paper, researchers demonstrate that a family of proteins, the 14-3-3 proteins, interact with LRRK2.

Researchers report the development of a validated new model that can be used to forecast the current and future burden of postmenopausal osteoporosis in different national settings.

Scientists have identified a critical enzyme that keeps traffic flowing in the right direction in the nervous system, and the finding could eventually lead to new treatments for conditions such as Alzheimer's and Parkinson's disease.

In a surprising and unexpected discovery, scientists have found that a single type of gene acts as a master organizer of motor neurons in the spinal cord. The finding could help scientists develop new treatments for diseases such as Lou Gehrig's disease or spinal cord injury.

Cancer immunotherapy calls for revised clinical endpoints that differ from those used for chemotherapy, according to a new article.

Biologists studying human reproduction have identified what is likely the major contributing factor to the maternal age-associated increase in aneuploidy, the term for an abnormal number of chromosomes during reproductive cell division.

A type of neuron that, when malfunctioning, has been tied to epilepsy, autism and schizophrenia is much more complex than previously thought, researchers report.

Researchers have developed a revolutionary, noninvasive way of quickly predicting the future health of premature infants, an innovation that could better target specialized medical intervention and reduce health-care costs.

People who sleep less than six hours a night may be three times more likely to develop a condition which leads to diabetes and heart disease, according to researchers.

Patients with colon cancer who used multivitamins during and after being treated with post-surgical chemotherapy did not reduce the risk of the cancer returning or their dying from it, according to researchers. In a study of 1,038 patients with stage III colon cancer, the researchers found that while multivitamin use had no beneficial effect on patients' outcomes, it also did not have a detrimental effect.